Europe Infant, Child, and Maternal Probiotic Supplements Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Form (Capsules and Soft Gels, Gummies, Liquid, and Others) and End User (Infant and Toddler, Children, and Maternal Women)

Description

List of Tables

The Europe infant, child, and maternal probiotic supplements market is expected to grow from US$ 179.18 million in 2022 to US$ 287.30 million by 2028; it is estimated to grow at a CAGR of 8.2% from 2022 to 2028.

Pregnant women are seeking various alternatives to support their fitness and the health of their unborn babies. Digestive problems, such as constipation, diarrhea, acidity, and inflammation, are common during pregnancy. Recently, the demand for probiotic dietary supplements among pregnant women has increased. A thoroughly researched probiotic strains help improve bowel movement and relieve constipation problems. Consumption of probiotic supplements in the regular diet help reduce inflammation, acidity, and bloating, and it also lowers the risk of vaginal infections, thus decreasing the chances of colic, eczema, and other allergies in newborn babies. Further, it also reduces the risk of pre-eclampsia in pregnant women, a health condition resulting in high blood pressure and high protein levels in urine. Probiotic supplements also ensure better immunity for pregnant women, which helps fight chronic diseases and ensure the baby's good health. Lactobacillus acidophilus, Bifidobacterium bifidum, and Saccharomyces boulardii are among the most effective and widely used probiotic strains in prenatal probiotic supplements. These strains help maintain a healthy intestinal flora and reduce the risk of various allergies, diseases, and complications, including gestational diabetes and pre-eclampsia. The growing awareness about the benefits of probiotic supplements among pregnant women and newborns is substantially driving the infant, child, and maternal probiotic supplements market growth.

With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe infant, child, and maternal probiotic supplements market growth at a notable CAGR during the forecast period.

Europe Infant, Child, and Maternal Probiotic Supplements Market Revenue and Forecast to 2028 (US$ Million)

Europe Infant, Child, and Maternal Probiotic Supplements Market Segmentation

The market for Europe infant, child, and maternal probiotic supplements market is segmented into form, end user, and country. Based on form, the market is categorized into capsules and soft gels, gummies, liquid, and others. Based on end user, the market is segmented into infant and toddler, children, and maternal women. Based on country, the Europe infant, child, and maternal probiotic supplements market is segmented into Germany, the UK, France, Italy, Russia, and the Rest of Europe.

Europe Infant, Child, and Maternal Probiotic Supplements Market - Companies Mentioned

Bayer Corporation, Nestle S.A., BioGaia AB, and Nordic Naturals are a few major companies operating in the Europe infant, child, and maternal probiotic supplements market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe Infant, Child, and Maternal Probiotic Supplements Market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in Europe Infant, Child, and Maternal Probiotic Supplements Market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Product Code: BMIRE00027134

1. Introduction

1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation

2. Key Takeaways

3. Research Methodology

3.1 Scope of the Study
3.2 Research Methodology
- 3.2.1 Data Collection:
- 3.2.2 Primary Interviews:
- 3.2.3 Hypothesis Formulation:
- 3.2.4 Macro-economic Factor Analysis:
- 3.2.5 Developing Base Number:
- 3.2.6 Data Triangulation:
- 3.2.7 Country Level Data:
- 3.2.8 Limitations and Assumptions:

4. Europe Infant, Child, and Maternal Probiotic Supplements Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Expert Opinion
4.4 Ecosystem Analysis

5. Europe Infant, Child, and Maternal Probiotic Supplements Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Rising Demand for Probiotic Supplements in Paediatric Nutrition
- 5.1.2 Growing Awareness Regarding Benefits of Probiotic Supplements among Pregnant Women
5.2 Market Restraints
- 5.2.1 Consumer Perceptions on Probiotic Supplements for Newborn
5.3 Market Opportunities
- 5.3.1 Surging Demand in Developing Regions
5.4 Future Trends
- 5.4.1 Increasing Research and Development in Infant and Maternal Probiotics Space
5.5 Impact Analysis of Drivers and Restraints

6. Europe Infant, Child, and Maternal Probiotic Supplements -Market Analysis

6.1 Europe Infant, Child, and Maternal Probiotic Supplements Market -Revenue and Forecast to 2028 (US$ Thousand)

7. Europe Infant, Child, And Maternal Probiotic Supplements Market Analysis - By Form

7.1 Overview
7.2 Europe Infant, Child, And Maternal Probiotic Supplements Market, By Form (2021 and 2028)
7.3 Capsules and Softgels
- 7.3.1 Overview
- 7.3.2 Capsules and Softgels: Europe Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
7.4 Gummies
- 7.4.1 Overview
- 7.4.2 Gummies: Europe Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
7.5 Liquid:
- 7.5.1 Overview
- 7.5.2 Liquid: Europe Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: Europe Infant, Child, And Maternal Probiotic Supplements Market- Revenue and Forecast to 2028 (US$ Thousand)

8. Europe Infant, Child, And Maternal Probiotic Supplements Market Analysis - By End User

8.1 Overview
8.2 Europe Infant, Child, And Maternal Probiotic Supplements Market, By End User (2021 and 2028)
8.3 Infant and Toddler
- 8.3.1 Overview
- 8.3.2 Infant and Toddler: Europe Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
8.4 Children
- 8.4.1 Overview
- 8.4.2 Children: Europe Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
8.5 Maternal Women
- 8.5.1 Overview
- 8.5.2 Maternal Women: Europe Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)

9. Europe Infant, Child, and Maternal Probiotic Supplements Market - Country Analysis

9.1 Europe: Infant, Child, and Maternal Probiotic Supplements Market
- 9.1.1 Europe: Europe Infant, Child, and Maternal Probiotic Supplements Market -Revenue and Forecast to 2028 (US$ Thousand)
- 9.1.2 Europe: Infant, Child, and Maternal Probiotic Supplements Market, by Key Country
  - 9.1.2.1 Germany: Europe Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 9.1.2.1.1 Germany: Infant, Child, and Maternal Probiotic Supplements Market, By Form
    - 9.1.2.1.2 Germany: Infant, Child, and Maternal Probiotic Supplements Market, by End User
  - 9.1.2.2 UK: Europe Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 9.1.2.2.1 UK: Infant, Child, and Maternal Probiotic Supplements Market, By Form
    - 9.1.2.2.2 UK: Infant, Child, and Maternal Probiotic Supplements Market, by End User
  - 9.1.2.3 France: Europe Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 9.1.2.3.1 France: Infant, Child, and Maternal Probiotic Supplements Market, By Form
    - 9.1.2.3.2 France: Infant, Child, and Maternal Probiotic Supplements Market, by End User
  - 9.1.2.4 Italy: Europe Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 9.1.2.4.1 Italy: Infant, Child, and Maternal Probiotic Supplements Market, By Form
    - 9.1.2.4.2 Italy: Infant, Child, and Maternal Probiotic Supplements Market, by End User
  - 9.1.2.5 Russia: Europe Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 9.1.2.5.1 Russia: Infant, Child, and Maternal Probiotic Supplements Market, By Form
    - 9.1.2.5.2 Russia: Infant, Child, and Maternal Probiotic Supplements Market, by End User
  - 9.1.2.6 Rest of Europe: Europe Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 9.1.2.6.1 Rest of Europe: Infant, Child, and Maternal Probiotic Supplements Market, By Form
    - 9.1.2.6.2 Rest of Europe: Infant, Child, and Maternal Probiotic Supplements Market, by End User

10. Industry Landscape

10.1 Overview
10.2 Product launch
10.3 Expansion

11. Company Profiles

11.1 Bayer Corporation
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Nestle S.A.
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 BioGaia AB
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Nordic Naturals
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments

12. Appendix

12.1 About The Insight Partners
12.2 Word Index